资讯
20 小时
Clinical Trials Arena on MSNMSD and Daiichi announce first subject dosing in prostate cancer trialMSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab ...
Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...
Airport screening in the U.S. detected the new variant in travelers arriving in California, Washington state, Virginia and ...
Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial ...
Durvalumab (Imfinzi) is a PD-L1–blocking antibody that has 3 indications for non–small cell lung cancer (NSCLC). February ...
Jodi Hilton Harvard’s Kseniia Petrova is one of causes at a protest of Trump administration policies April 12 at the ...
Lundbeck US, the US subsidiaries of H. Lundbeck A/S, today announced it will present one oral and eight poster presentations at the 67th Annual Scientific Meeting of the American Headache Society (AHS ...
The main culprit for increased UTIs in menopausal women is the drop in estrogen levels. Estrogen plays a crucial role in ...
From the practical wisdom of emphasising exercise to improve survival in colon cancer to the association of glucagon-like ...
THIS YEAR, the vibrant city of Amsterdam, the Netherlands played host to the European Association for the Study of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果